
Global
51 blogs about the topic

An Excellent 12th GHTF Conference explores answers on the future of the GHTF
Just sitting at the airport after what was an excellent Global Harmonization Task Force Conference. Well done Steve Dibert and his crew, not to mention Health Canada. Who says regulatory affairs is boring! This conference really put the moose among the pigeons! We had a truly gripping opening session from Dr. Robert Jackson, the renowned […]

Posted on 12.05.2009
Russia in the global economic storm
The EPC organised on May 6th a policy dialogue with the World Bank on the topic: “Russia in the global economic storm” and presented its latest Economic Report dated March 2009 and available here. The numbers of the World Bank, even though considered by the key note as “educated guesses” are still the best available […]

Posted on 06.05.2009
MassMEDIC Annual Meeting: Reflections on industry clinician collaboration
Sitting on Boston’s south shore, the John F. Kennedy Pesidential Library is both imposing yet not over-stated. A rare treat for me was the opportunity to address the annual meeting of MassMEDIC, the largest regional medical technology association in the USA – and that means the world, I am sure! The speaker’s podium has a […]

Patient Power across Europe
On one of those beautiful clear Spring mornings here in Brussels, it was a rare pleasure to head out early for breakfast with the Health Consumer Powerhouse. Housed in a beautiful high ceilinged and gilt embellished office near De Brouckere, Health Consumer Powerhouse is a champion for European consumers of healthcare (you and me) and […]

Ageing and health: challenges ahead
Today at the European Business Summit in Brussels a workshop was organized focusing on health entitled “Ageing and health: Pay for the grey”. The distinguished panel included Androulla Vassilliou, European Commissioner for Health, AGE, the European Older People’s platform, and the Japanese ambassador to the EU and last but not least industry representatives. Not surprisingly, […]

The role of EMEA in future regulation: consensus amongst experts
It was with some trepidation that I placed myself in the ‘lions den’ of the pharmaceutical industry at the annual Euromeeting of the Drug Information Association in Berlin today. Sharing a platform to discuss the evolution of medical device regulation with Mdme Georgette Lalis of the EU Commission and David Feigal, former FDA Commissioner, proved […]